Ambulatory Surgery Center (ASC) Market Size, Share and Growth Outlook, 2026

Ambulatory Surgery Center (ASC) Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Ambulatory Surgery Center (ASC) Market size is forecast to increase from $186.46 Billion in 2026 to $317.99 Billion in 2034 at a CAGR of 6.9% between 2026 and 2034.

The Ambulatory Surgery Center (ASC) market report provides detailed analysis and outlook of Ambulatory Surgery Center (ASC) segments including By Ownership (Physician Only, Hospital Only, Corporation Only), By Specialty Type (Multi-Specialty ASCs, Single Specialty ASCs), By Surgery (Ophthalmology, Orthopedic & Podiatry, Gastroenterology / Endoscopy, Pain Management & Spinal Injections, Otolaryngology, General Surgery, Obstetrics / Gynecology, Plastic / Cosmetic Surgery, Cardiovascular & Dental Surgeries), By Service Offering (Clinical Solutions, Non-Clinical Solutions, Healthcare IT Outsourcing Services) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Ambulatory Surgery Center (ASC) Industry Overview

The Ambulatory Surgery Center (ASC) industry continues to expand as healthcare systems, physicians, and payers increasingly shift surgical procedures from traditional inpatient hospitals to specialized outpatient facilities. This transition is being supported by favorable reimbursement policies, strategic facility expansion initiatives, and growing investments in operational technologies designed to improve efficiency and patient outcomes. ASCs are becoming an increasingly important component of modern healthcare delivery by offering cost-effective surgical care, streamlined workflows, and specialized treatment environments across multiple clinical disciplines.

CMS Reimbursement Updates Accelerating Procedure Migration

A key driver shaping the ASC industry is the ongoing expansion of procedures eligible for outpatient reimbursement. The Centers for Medicare & Medicaid Services updated the Ambulatory Surgical Center Covered Procedures List, adding several complex orthopedic and cardiovascular procedures that now qualify for Medicare reimbursement when performed in an ASC setting. This regulatory update reflects the continuing migration of surgical volume away from inpatient hospital environments toward lower-cost outpatient facilities. The inclusion of advanced orthopedic and cardiovascular interventions broadens the scope of services that ASCs can provide and supports healthcare system efforts to improve cost efficiency while maintaining high standards of patient care. As reimbursement policies continue to evolve, ASCs are positioned to capture a larger share of surgical procedures traditionally performed in hospital settings.

Strategic Facility Expansion Strengthening Market Presence

Industry growth is also being supported by strategic partnerships and new facility development initiatives. AmSurg, one of the largest ambulatory surgery center operators in the United States, announced a joint-venture partnership with a major health system in the Pacific Northwest to establish two new multi-specialty surgery centers. These facilities are specifically designed to focus on total joint replacement procedures and spine surgeries, two high-demand segments within outpatient surgical care. The centers will utilize AmSurg’s proprietary clinical and administrative software platforms to standardize care delivery, improve operational consistency, and optimize patient outcomes. Such collaborations between ASC operators and health systems are becoming increasingly common as organizations seek to expand access to specialized outpatient surgical services.

Technology Integration Enhancing Operational Efficiency

Technology adoption is emerging as a major competitive differentiator across the ASC landscape. Leading operators, including Surgery Partners and other multi-site providers, are investing in artificial intelligence-driven scheduling systems and automated surgical inventory management platforms to address operational bottlenecks. Advanced supply chain tracking technologies are being deployed to monitor surgical consumables, reduce waste, and improve inventory visibility. At the same time, AI-powered scheduling tools help optimize case flow and reduce turnaround times between procedures. These innovations support greater efficiency, improved resource utilization, and enhanced profitability while enabling ASCs to manage increasing procedure volumes in a highly competitive healthcare environment.

Ambulatory Surgery Center (ASC) Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Ambulatory Surgery Center (ASC) market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Tenet Healthcare Corporation , HCA Healthcare, Inc., Optum, Inc. , Surgery Partners, Inc., AMSURG (Envision Healthcare), SurgCenter Development, Regent Surgical Health, ValueHealth, LLC (NueHealth), Covenant Physician Partners, Inc., Ardent Health Services. The Ambulatory Surgery Center (ASC) market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Ambulatory Surgery Center (ASC) industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Ambulatory Surgery Center (ASC) Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Ambulatory Surgery Center (ASC) companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Ambulatory Surgery Center (ASC) markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Ambulatory Surgery Center (ASC) Market Competitive Benchmarking and Company Analysis

Leading companies in Ambulatory Surgery Center (ASC) industry include- Tenet Healthcare Corporation , HCA Healthcare, Inc., Optum, Inc. , Surgery Partners, Inc., AMSURG (Envision Healthcare), SurgCenter Development, Regent Surgical Health, ValueHealth, LLC (NueHealth), Covenant Physician Partners, Inc., Ardent Health Services. The Ambulatory Surgery Center (ASC) market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Ambulatory Surgery Center (ASC) Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Ambulatory Surgery Center (ASC) market remains one of the strongest-performing segments in the country.
The US Ambulatory Surgery Center (ASC) Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Ambulatory Surgery Center (ASC) market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Ambulatory Surgery Center (ASC) industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Ambulatory Surgery Center (ASC) markets

Canada's strong Ambulatory Surgery Center (ASC) sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Ambulatory Surgery Center (ASC) market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Ambulatory Surgery Center (ASC) Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Ambulatory Surgery Center (ASC) market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Ambulatory Surgery Center (ASC) population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Ambulatory Surgery Center (ASC) industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Ambulatory Surgery Center (ASC) market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Ambulatory Surgery Center (ASC) sales through 2034

France Ambulatory Surgery Center (ASC) companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Ambulatory Surgery Center (ASC) Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Ambulatory Surgery Center (ASC) distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Ambulatory Surgery Center (ASC) Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Ambulatory Surgery Center (ASC) market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Ambulatory Surgery Center (ASC) industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Ambulatory Surgery Center (ASC) industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Ambulatory Surgery Center (ASC) Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Ambulatory Surgery Center (ASC) market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Ambulatory Surgery Center (ASC) market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Ambulatory Surgery Center (ASC) Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Ambulatory Surgery Center (ASC) Market Segmentation

By Ownership
Physician Only
Hospital Only
Corporation Only
By Specialty Type
Multi-Specialty ASCs
Single Specialty ASCs
By Surgery
Ophthalmology
Orthopedic & Podiatry
Gastroenterology / Endoscopy
Pain Management & Spinal Injections
Otolaryngology
General Surgery
Obstetrics / Gynecology
Plastic / Cosmetic Surgery
Cardiovascular & Dental Surgeries
By Service Offering
Clinical Solutions
Non-Clinical Solutions
Healthcare IT Outsourcing Services

Top Companies in Ambulatory Surgery Center (ASC) Industry

Tenet Healthcare Corporation
HCA Healthcare, Inc.
Optum, Inc.
Surgery Partners, Inc.
AMSURG (Envision Healthcare)
SurgCenter Development
Regent Surgical Health
ValueHealth, LLC (NueHealth)
Covenant Physician Partners, Inc.
Ardent Health Services

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025